中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
16期
79-79,88
,共2页
邹锋%董林%杨俊涛%李新娉%李兵%马雪
鄒鋒%董林%楊俊濤%李新娉%李兵%馬雪
추봉%동림%양준도%리신빙%리병%마설
肺癌%医院感染%病原菌%耐药性
肺癌%醫院感染%病原菌%耐藥性
폐암%의원감염%병원균%내약성
Lung cancer%Nosocomial infection%Pathogens%Drug resistance
目的:了解肺癌患者医院感染的病原菌分布及耐药性。方法收集2005年6月至2013年6月入住我院的271例肺癌患者的临床资料,进行病原菌分布及耐药性情况分析。结果271例肺癌患者发生医院感染47例,感染率为17.34%,感染51例次,感染例次率18.82%;以呼吸系统感染为主,占72.54%;病原菌中革兰阴性菌、革兰阳性菌、真菌分别占55.32%、38.30%、6.38%;病原菌对青霉素、头孢曲松、左氧氟沙星等耐药率较高。结论肺癌患者是医院感染的易感人群,医务人员应针对肺癌患者院内感染的病原菌分布及耐药特点进行有效防控。
目的:瞭解肺癌患者醫院感染的病原菌分佈及耐藥性。方法收集2005年6月至2013年6月入住我院的271例肺癌患者的臨床資料,進行病原菌分佈及耐藥性情況分析。結果271例肺癌患者髮生醫院感染47例,感染率為17.34%,感染51例次,感染例次率18.82%;以呼吸繫統感染為主,佔72.54%;病原菌中革蘭陰性菌、革蘭暘性菌、真菌分彆佔55.32%、38.30%、6.38%;病原菌對青黴素、頭孢麯鬆、左氧氟沙星等耐藥率較高。結論肺癌患者是醫院感染的易感人群,醫務人員應針對肺癌患者院內感染的病原菌分佈及耐藥特點進行有效防控。
목적:료해폐암환자의원감염적병원균분포급내약성。방법수집2005년6월지2013년6월입주아원적271례폐암환자적림상자료,진행병원균분포급내약성정황분석。결과271례폐암환자발생의원감염47례,감염솔위17.34%,감염51례차,감염례차솔18.82%;이호흡계통감염위주,점72.54%;병원균중혁란음성균、혁란양성균、진균분별점55.32%、38.30%、6.38%;병원균대청매소、두포곡송、좌양불사성등내약솔교고。결론폐암환자시의원감염적역감인군,의무인원응침대폐암환자원내감염적병원균분포급내약특점진행유효방공。
Objective To explore the distribution and drug resistance of pathogens of nosocomial infections in the lung cancer patients. Methods The clinical information and data of 271 inpatients with lung cancer from Jun 2005 to Jun 2013 were collected, then distribution and drug resistance of pathogens of nosocomial infections were analyzed. Results Totally 271 cases of lung cancer patients, the infections occurred in 47 cases with the infection rate of 17.34%.There were 51 times of case infection, with the rate of case infection times of 18.82%.The main infection site was respiratory system(72.54%).The pathogenic bacteria were gram-negative bacteria(55.32%),gram-positive bacteria(38.30%),and fungus(6.38%).Most of the pathogens were highly resistant to penicillin, ceftriaxone, and levofloxacin. Conclusion The lung cancer inpatients are the susceptible population. Medical staff should pay more attention to the related factors of the nosocomial infections, and take positive and effective measures for preventive control.